Ruiyu Mou
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Methodological considerations for a deep learning-based prescription framework for traditional Chinese medicine.
Journal: British journal of pharmacology
Published: January 04, 2026
Application of organoids in precision immunotherapy of lung cancer (Review).
Journal: Oncology letters
Published: May 11, 2023
Developing a Core Outcome Set for Assessing Clinical Safety Outcomes of Prostate Cancer in Clinical Trials of Traditional Chinese Medicine: Protocol for a Mixed Methods Study.
Journal: JMIR research protocols
Published: February 25, 2023
Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis.
Journal: Frontiers in immunology
Published: February 02, 2023
RGN as a prognostic biomarker with immune infiltration and ceRNA in lung squamous cell carcinoma.
Journal: Scientific reports
Published: November 22, 2022
EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients.
Journal: Frontiers in cell and developmental biology
Published: December 26, 2021
Hispidulin inhibits proliferation, migration, and invasion by promoting autophagy via regulation of PPARγ activation in prostate cancer cells and xenograft models.
Journal: Bioscience, biotechnology, and biochemistry
Published: August 31, 2020
Anticancer effects of curcumin on nude mice bearing lung cancer A549 cell subsets SP and NSP cells.
Journal: Oncology letters
Published: November 17, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026